第10章 市場區隔:各產品類型

第11章 全球流感治療藥市場

第12章 全球流感疫苗市場

第13章 地區區分

第14章 購買標準

第15章 市場成長因素

第16章 成長因素與其影響

第17章 市場課題

第18章 成長因素與課題的影響

第19章 市場趨勢

第20章 趨勢與其影響

第21章 業者情勢

第22章 主要供應商分析

AstraZeneca

主要資料

產業概要

產品區隔

產業策略

收益:各產業分類

收益比較

銷售額收益:各區域區隔

主要的發展

SWOT分析

F. Hoffmann-La Roche

GlaxoSmithKline

Novartis

Sanofi Pasteur

第23章 相關報告

圖表清單

目錄

Product Code: IRTNTR4394

About Influenza

Influenza is a contagious respiratory disease caused by influenza viruses. These viruses infect the nose, throat, and lungs causing mild to severe illness. The disease can be fatal in some cases. Elderly people, young children, and people with medical conditions including liver disorders, blood disorders, kidney disorders, chronic lung disease, asthma, and neurodevelopmental and neurological conditions are at a higher risk of getting infected. Influenza vaccines are administered for active immunization against influenza virus. This, in turn, confers protection against influenza disease. Vaccination of high-risk groups prevents unnecessary hospitalizations and premature deaths resulting due to influenza.

TechNavio's analysts forecast the Global Influenza market to grow at a CAGR of 8.10 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Influenza market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the sales of various vaccines and drugs administered to prevent and treat human infection caused by influenza virus.

TechNavio's report, the Global Influenza Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Influenza market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Americas

APAC

EMEA

Key Vendors

AstraZeneca

F. Hoffmann-La Roche

GlaxoSmithKline plc

Novartis

Sanofi Pasteur

Other Prominent Vendors

Abbott

Baxter International

bioCSL

Crucell

Mitsubishi Tanabe Pharma

Protein Sciences

Serum Institute of India

Sinovac Biotech

Zydus Cadila

Market Driver

Increased Awareness about Influenza

For a full, detailed list, view our report

Market Challenge

Antigenic Drift of Influenza Virus

For a full, detailed list, view our report

Market Trend

Emergence of Quadrivalent Vaccines for H1N1 Influenza

For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2018 and what will the growth rate be

What are the key market trends

What is driving this market

What are the challenges to market growth

Who are the key vendors in this market space

What are the market opportunities and threats faced by the key vendors